2020 OptimEyes

20|20 OptimEyes Technologies - Biotechnology spin-out company from McMaster University located in Hamilton, Canada | 20|20 OptimEyes Technologies is a biotechnology spin-out company from McMaster University located in Hamilton, Ontario, Canada. We are developing a transformative drug delivery platform for ocular diseases normally controlled by eye drops. Using a patented technology formulation, initially targeted for glaucoma and dry eye diseases, we are able to change the dosing paradigm from twice daily to once or twice weekly. This will revolutionize treatment for patients, improving their comfort, compliance and clinical outcomes.